Faeth Therapeutics, Inc. Public Float
Faeth Therapeutics, Inc. (FTH) had Public Float of $7.10 million as of 2025-06-30, per its 10-K/A filed 2026-06-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-06-02
- 2025-06-30: Entity Public Float $7.10M.
- 2024-06-28: Entity Public Float $10.30M.
- 2023-06-30: Entity Public Float $18.70M.
- 2022-06-30: Entity Public Float $36.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $7.10M 10-K/A · filed 2026-06-02 |
| 2024-06-28 | $10.30M 10-K · filed 2025-03-28 |
| 2023-06-30 | $18.70M 10-K · filed 2024-02-29 |
| 2022-06-30 | $36.40M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $204.00M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |